Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Ali Ataya

Pulmonary Vascular Med · UF

View

Dr. Naftali Kaminski

Interstitial Lung Disease · Yale College

View

Dr. Auston Stiefer

Interstitial Lung Disease · CU Anschutz Medical Campus

View

Dr. Justin Zhang

Critical Care · UCLA

View

Dr. Panagis Galiatsatos

Critical Care · Johns Hopkins

View

Dr. MeiLan Han

Asthma & COPD · UMHS

View

Dr. Kevin Chung

Critical Care · SeaStar Medical

View

Dr. Diego J. Maselli

Asthma & COPD · UTHSCSA

View

Dr. Amos E. Dodi

Critical Care · MMC

View

Dr. Imre Noth

Interstitial Lung Disease · University of Virginia

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms

    Overview

    Fatty Acid and Oxylipin Metabolism Differentiate Isolated Postcapillary From Combined Pre- and Postcapillary Pulmonary Hypertension.

    Sep 10, 2026DOI: 10.1161/circheartfailure.125.014073Journal ArticleAHA

    Written by: Mona AlotaibiAmber TangNancy SunIan GurholtEmma YuguchiKari RobertsIoana PrestonRod WarburtonJason X-J YuanNick H KimStephen Y ChanMohit JainSusan ChengNicholas S Hill

    Find these authors on Roon

    NH
    Dr. Nicholas Hill
    Pulmonary Vascular Med · Tufts

    Summary

    BACKGROUND: Pulmonary hypertension (PH) due to left-sided heart disease (Group 2 PH) is the most common type of PH and comprises 2 subtypes with distinct clinical profiles and outcomes: isolated postcapillary PH and combined pre- and postcapillary PH (Cpc-PH). Bioactive lipid derivatives may underlie these divergent subphenotypes. This study aimed to investigate the molecular heterogeneity underlying Group 2 PH subtypes and identify shared pathways between Cpc-PH and pulmonary arterial hypertension (PAH).METHODS: In a cross-sectional study, we profiled plasma bioactive lipids using liquid chromatography-mass spectrometry in 128 patients with isolated postcapillary PH (n=21), Cpc-PH (n=69), or PAH (n=38), as well as in plasma samples from animal models of severe PH.RESULTS: Of the 844 profiled metabolites, 158 differed between Cpc-PH and isolated postcapillary PH at a false discovery rate of q<0.05. Of those, 28 were higher in Cpc-PH, particularly those in the polyunsaturated fatty acid and fatty acyl esters of hydroxy fatty acid pathways. Notably, 24 of these 28 did not differ from PAH, indicating a PAH-like bioactive lipid signature. Several metabolites, including adrenic acid, linoleic acid, docosatrienoic acid, palmitoleic acid, and fatty acyl esters of hydroxy fatty acids, were associated with increased mortality. These findings were corroborated in the Su/Hx rat model of PAH, where a subset of Cpc-PH-elevated metabolites was similarly increased.CONCLUSIONS: Cpc-PH exhibits a distinct, PAH-like metabolomic signature characterized by higher polyunsaturated fatty acids and fatty acyl esters of hydroxy fatty acids and lower pro-resolvin/vasodilatory oxylipins compared with isolated postcapillary PH. These findings have implications for PH classification, may inform diagnostic strategies, and nominate lipid pathways for therapeutic targeting.
    NHDr. Nicholas Hill

    Dr. Nicholas Hill

    Pulmonology & Critical Care · Pulmonary Vascular Medicine
    Tufts Medical Center
    nicholashill